Preservation of Dark Adaptation, Visual Field and Macular Microperimetry in Patients with Proliferative Diabetic Retinopathy Treated with Pegaptanib Sodium Versus Laser Photocoagulation

Trial Profile

Preservation of Dark Adaptation, Visual Field and Macular Microperimetry in Patients with Proliferative Diabetic Retinopathy Treated with Pegaptanib Sodium Versus Laser Photocoagulation

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jul 2011

At a glance

  • Drugs Pegaptanib (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2011 New trial record
    • 26 Jun 2011 Results were presented as a late-breaking abstract at the 71st Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top